WCG Launches AIMS 4.1 Platform


Applied Clinical Trials

WCG ACI Clinical has launched the latest iteration of its proprietary AIMS. AIMS 4.1 offers users of WCG's endpoint adjudication solutions an enhanced interface and workflow experience.

To learn more about AIMS 4.1, click here. 

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.